BioSpace News Archive

Biotech Bay

Cerus Corporation Announces Public Offering of Common Stock

Cerus Corporation (Nasdaq: CERS) announced today that it has commenced a registered underwritten public offering of $50.0 million of its common stock

January 28, 2020
·
3 min read
Business

Inogen to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday, February 25, 2020

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter and full year 2019 financial results after market close on Tuesday, February 25, 2020

January 28, 2020
·
1 min read
Policy

European Medicines Agency Validates Kite’s Marketing Application for Company’s Second CAR T Cell Therapy

Investigational KTE-X19 To Be First Chimeric Antigen Receptor (CAR) T Cell Therapy for Mantle Cell Lymphoma in Europe if Approved

January 28, 2020
·
5 min read
Business

Agilent Technologies to Webcast First Quarter Fiscal Year 2020 Financial Results Conference Call

Agilent Technologies, Inc. will release first-quarter fiscal year 2020 financial results after the stock market closes on Feb. 18.

January 28, 2020
·
1 min read
Global Bilirubin Blood Test Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Danaher Corp. | Technavio

Technavio has announced its latest market research report titled global bilirubin blood test market 2020-2024

January 28, 2020
·
4 min read
Business

Lattice Biologics Ltd. Reports Year End 2019 Results and Q1 Preliminary Q1 2020 Revenues

Lattice Biologics Ltd. announces financial results for the fiscal year end 2019 and preliminary revenues for Q1 2020..

January 28, 2020
·
8 min read
Deals

Annovis Bio Announces Pricing of Initial Public Offering - Jan. 28, 2020

Annovis Bio, Inc. announced the pricing of its initial public offering of 2,000,000 shares of its common stock at a price to the public of $6.00 per share, for gross proceeds of $12,000,000 before deducting underwriting discounts, commissions and offering expenses.

January 28, 2020
·
3 min read
Pharm Country

Merck Announces Second-Quarter 2020 Dividend

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.61 per share of the company’s common stock for the second quarter of 2020.

January 28, 2020
·
3 min read
Biotech Beach

Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that on January 24, 2020, the U.S. Food and Drug Administration (“FDA”) issued a “MINOR” Complete Response Letter (“CRL”) for its Abbreviated New Drug Application (“ANDA”) for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose.

January 28, 2020
·
3 min read
Business

Establishment Labs Announces Preliminary Results for Fourth Quarter and Full Year 2019; Reports Record Revenue

Establishment Labs Holdings Inc., a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – announced preliminary financial results for the fourth quarter and full year 2019, with total revenue growth for the quarter of 43% to 49%.

January 28, 2020
·
5 min read